Dosage and PD Study of Eftrenonacog-alfa

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

NCT00703911 ·Status: COMPLETED

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

NCT06941870 ·Status: RECRUITING ·Phase: PHASE4

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

NCT06579144 ·Status: RECRUITING ·Phase: PHASE1

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

NCT01234545 ·Status: COMPLETED

ATHN 11: Liver Transplantation Outcomes Study

NCT04055051 ·Status: COMPLETED

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

NCT00950170 ·Status: COMPLETED ·Phase: PHASE4

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

NCT00710619 ·Status: COMPLETED

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

NCT02250560 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age

NCT00759655 ·Status: TERMINATED ·Phase: PHASE3

Study Evaluating ReFacto AF in Severe Hemophilia A

NCT00037544 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B

NCT01233440 ·Status: COMPLETED ·Phase: PHASE1

Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A

NCT01790828 ·Status: COMPLETED

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients

NCT00914459 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

NCT03655340 ·Status: COMPLETED

Sonography and Haemophilia

NCT04550988 ·Status: UNKNOWN

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

NCT04644575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881 ·Status: COMPLETED

Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)

NCT01579903 ·Status: COMPLETED ·Phase: PHASE1

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery

NCT01579968 ·Status: COMPLETED

Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A

NCT02461992 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A

NCT05042440 ·Status: COMPLETED ·Phase: PHASE1

A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A

NCT04161495 ·Status: COMPLETED ·Phase: PHASE3

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

NCT03901755 ·Status: COMPLETED

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

NCT01949792 ·Status: COMPLETED ·Phase: PHASE1